Диссертация (1141026), страница 24
Текст из файла (страница 24)
Magen E. Prevalence of dermatologic diseases among patients with selectiveimmunoglobulin A deficiency. / E. Magen, A. Masalha, D.A. Waitman et al//Allergy Asthma Proc. – 2017. – V.38, n.1. – P.70-77.158. Malik K. An Update on the Pathophysiology of Atopic Dermatitis. / K. Malik,K.D. Heitmiller, T. Czarnowicki // Dermatol. Clin. – 2017. - V.35, n.3. – P.317326.159. Matysiak-Budnik T. Review article: rebamipide and the digestive epithelialbarrier.
/ T. Matysiak-Budnik, M. Heyman, F. Mégraud // Aliment. Pharmacol.Ther. – 2003. – V.18, Suppl. 1. – P.55-62.160. McFadden J.P. The Hapten-Atopy hypothesis II: the ‘cutaneous haptenparadox. / J.P. McFadden, R.J. Dearman, J.M. White et al // Clin. Exp. Allergy.– 2011. – V.41. – P.327-337.161. Metchnikoff E. et al. The Evolutionary Biology Papers of Elie Metchnikoff./ Dordrecht, Kluwer A. // – 2000.
– Р. 207–216. originally published in 1892.162. Metchnikoff E. Immunity in Infective Diseases. Reprinted by: New York. /R.C. Johnston // - 1968. originally published in 1901. – Р.7-62.163. McGrath J.A. Filaggrin and the great epidermal barrier grief. / J.A. McGrath//Austral. J.
Dermatol. - 2008. - V.49, n.2. - P. 67-73.144164. Moffatt M.F. A large-scale, consortium based genomewide association studyof asthma. / M.F. Moffatt, G. Gut, F. Demenais et al // N. Engl. J. Med. - 2010.- V.363, n.13. - P. 1211-1222.165. Moreno A.S. Targeting the T Helper 2 Inflammatory Axis in AtopicDermatitis.
/ A.S. Moreno, R. McPhee, L.K. Arruda, M.D. Howell // Int. Arch.Allergy Immunol. – 2016. – V.171, n.2. – P.71-80.166. Morita H. Innate lymphoid cells in allergic and nonallergic inflammation . /H. Morita, K. Moro, S. Koyasu // J. Allergy Clin. Immunol. – 2016. – V.138,n.5. – P.1253-1264.167. Moriyama M. Th1/Th2 Immune Balance and Other T Helper Subsets inIgG4-Related Disease. / M. Moriyama, S. Nakamura // Curr. Top.
Microbiol.Immunol. – 2017. – V.401. – P.75-83.168. Moiseeva O. Serological diagnostics of myocardium diseases based onmultivariate analysis of cardiotrophic autoantibodies’ profiles. / O. Moiseeva,L. Mitrofanova, E. Karelkina, D. Zverev, D. Lebedev, S. Skurydin, A. Poletaev// Open Journal of Immunology. 2012.
- Vol.2. - No.1. – P. 49-58.169. Muir A.B. Microbiome and its impact on gastrointestinal atopy. / A.B. Muir,A.J. Benitez, K. Dods et al // Allergy. – 2016. – V.71, n.9. – P.1256-1263.170. Muñoz F.C. Glycomacropeptide Attenuates Inflammation, Pruritus, and Th2ResponseAssociatedwith AtopicDermatitis Inducedby2,4-Dinitrochlorobenzene in Rat.
/ F.C. Muñoz, M.M. Cervantes, D. CervantesGarcía // J. Immunol. Res. – 2017. - 2017:6935402.171. Murakami K. Atopic dermatitis successfully treated by eradication ofHelicobacter pylori. / K. Murakami, T. Fujioka, A. Nishizono et al // J.Gastroenterol.
– 1996. - V.31, Suppl. 9. – P.77-82172. Namkung J.H. Association of polymorphisms in genes encoding IL-4, IL-13and their receptors with atopic dermatitis in a Korean population. / J.H.Namkung, J.E. Lee, E. Kim et al // Exp. Dermatol. - 2011. – V.20, n.11. - P.915-919.145173. Narożna B. Polymorphisms in the interleukin 4, interleukin 4 receptor andinterleukin 13 genes and allergic phenotype: A case control study. / B. Narozna,A. Hoffmann, P. Sobkowiak et al // Adv.
Med. Sci. – 2016. - V.61, n.1. – P.4045.174. Navarrete-Dechent C. Humoral and Cellular Autoreactivity to EpidermalProteins in Atopic Dermatitis. / C. Navarrete-Dechent, G. Pérez-Mateluna, S.Silva-Valenzuela et al //Arch. Immunol .Ther. Exp. (Warsz). – 2016. – V.64,n.6. – P.435-442.175. Nebert D.W. Analysis of the glutathione S-transferase (GST) gene family. /D.W.
Nebett, V. Vasiliou // Hum. Genomics. - 2004. - V.1, n.6. - P.460-464.176. Novak N. Putative association of a TLR9 promoter polymorphism withatopic eczema. / N. Novak, C.F. Yu, C. Bussmann et al //Allergy. - 2007. - V.62.- P. 766-772.177. Odhiambo J.A. Global variations in prevalence of eczema symptoms inchildren from ISAAC Phase Three. / J.A. Odhiambo, H.C. Williams, T.O.Clayton et al // J. Allergy Clin.
Immunol. - 2009. - V.124. - P. 1251-1258.178. On H.R. Filaggrin Mutation in Korean Patients with Atopic Dermatitis. / H.P.On, S.E. Lee, S.E. Kim et al // Yonsei Med. J. – 2017. – V.58, n.2. – P.395-400.179. Ozawa S.Genetic polymorphisms in xenobiotic metabolizing enzymes as adeterminant of susceptibility to environmental mutagens and carcinogens inhumans. //Yakugaku Zasshi.-1997.- Nov;Vol.l 17(10-11). P. 895-909.180. Ong P.Y. Endogenous antimicrobial peptides and skin infections in atopicdermatitis. / P.Y. Ong, T.
Ohtake, C. Brandt et al // N. Engl. J. Med. - 2002. V.34. - P. 1151-1160.181. Otsuka A. Possible new therapeutic strategy to regulate atopic dermatitisthrough upregulating filaggrin expression. / A. Otsuka, H. Doi, G. Egawa et al// J. Allergy Clin. Immunol. – 2014. – V.133, n.10. – P.139-146.182. Palmer C.N.A. Common loss-of-function variants of the epidermal barrierprotein filaggrin are a major predisposing factor for atopic dermatitis. / C.N.A.146Palmer, A.D. Irvine, A. Terron-Kwiatkowski et al // Nat.
Genet. – 2006. – V.38.– P. 441–446.183. Paoloni-Giacobino A. Genetic and nutrition // Clin. Nutr. – 2003. – V.22. –P.429-443.184. Park J.H. Eisenhu Insight into the role of TSLP in inflammatory boweldiseases. / J.H. Park, D.Y. Jeong, L. Peyrin-Biroulet et al // Autoimmun Rev. –2017.
– V.16, n.1. – P.55-63.185. Park K.D. The Pathogenetic Effect of Natural and Bacterial Toxins on AtopicDermatitis. / K.D. Park, S.C. Pak, K.K. Park // Toxins (Basel). – 2016. – V.9,n.1. - pii: E3.186. Paternoster L. Meta-analysis of genome-wide association studies identifiesthree new risk loci for atopic. / L. Paternoster, M.
Standl, C.M. Chen et al //Nat. Genet. – 2011. – V.44, n.2. – P.187-192.187. Pavanello S., Clonfero E. Biomarkers of genotoxic risk and metabolicpolymorphism. // Med. Lav.-2000. Sep.,Oct.,Vol.91(5). - P. 431-469.188. Pushparaj P.N. The cytokine interleukin-33 mediates anaphylactic shock. /P.N. Pyshparaj, H.K. Tay, S.C.H’ng et al // Proc. Natl. Acad. Sci. USA. - 2009.- V.
106. - P. 9773-9778.189. Peden D.B. Development of atopy and asthma: candidate environmentalinfluences and important periods of exposure. // Environ Health Perspect. 2000. Jun; Vol.108 (Suppl 3). - P. 475-482.190. Qian F.-H. Polymorphisms in the Toll-like Receptor 2 Subfamily and Risk ofAsthma: A Case-control Analysis in a Chinese Population. / F.-H. Qian, Q.Zhang, L. -F. Zhou et al // J. Investig. Allergol. Clin. Immunol.
- 2010. - V. 20,n.4. - P. 340-346.191. Quentmeier H. Cloning of human thymic stromal lymphopoietin (TSLP) andsignaling mechanisms leading to proliferation. / H. Quentmeier, H.G. Drexler,D. Fleckenstein et al // Leukemia. - 2001. - V. 15. - P. 1286-1292.147192. Reijmerink N.E. KHost-microbial interactions in childhood atopy: toll-likereceptor 4 (TLR4), CD14, and fecal Escherichia coli. / N.E. Reijmerink, P.A.van den Brandt, M. Kerkhof et al // J. Allergy Clin. Immunol. – 2010. – V.125,n.1.
– P.231-236.193. Roedl D. Serine protease inhibitor lymphoepithelial Kazal type-relatedinhibitor tends to be decreased in atopic dermatitis. / D. Roedl, C. TraidlHoffman, J. Ring et al // JEADV. - 2009. - V. 23. - P. 1263-1266.194. Saito Y. Randomized, double-blind, placebo-controlled, parallel-group studyof the effect of Lactobacillus paracasei K71 intake on salivary release ofsecretory immunoglobulin A.
/ Y. Saito, M. Fujii, T. Watanabe et al //Biosci. Microbiota. Food. Health. – 2017. – V.36, n.2. – P.55-63.195. Salimi M. Cysteinyl leukotriene E4 activates human group 2 innate lymphoidcells and enhances the effect of prostaglandin D2 and epithelial cytokines. / M.Salimi, L. Stöger, W. Liu et al // J. Allergy Clin. Immunol. – 2017. - Jan 20. pii: S0091-6749(17)30051-9.196.
Sandilands A. Prevalent and rare mutations in the gene encoding filaggrincause ichthyosis vulgaris and predispose individuals to atopic dermatitis. / A.Sandilands, G.M.O’Regan, H. Liao et al // J. Invest. Dermatol. - 2006. -V. 26,n.8. - P. 1770-1775.197. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in apopulation-based twin study. / F. Schultz Larsen // J. Am. Acad.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
